AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Drug Administration ScheduleTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelInfusions, IntravenousTaxoidsAntineoplastic Agents, PhytogenicMaximum Tolerated DoseTime FactorsDose-Response Relationship, DrugFluorouracilAntineoplastic AgentsCisplatinDouble-Blind MethodInjections, SubcutaneousCombined Modality TherapyDeoxycytidineAntibodies, Monoclonal, HumanizedAstheniaProspective StudiesLeucovorinAnemiaAdministration, OralPilot ProjectsNeutropeniaFollow-Up StudiesErythropoietinCamptothecinAntibodies, MonoclonalHemoglobinsSurvival AnalysisNeoplasmsSeasonsDisease-Free SurvivalLung NeoplasmsFeasibility StudiesCarboplatinSurvival RateMethotrexateHematinicsBody WeightRandom AllocationAntimetabolites, AntineoplasticNeoplasm MetastasisArea Under CurveNeoplasm StagingBreast NeoplasmsDoxorubicinRecombinant ProteinsAdenocarcinomaQuality of LifeAntibodies, Monoclonal, Murine-DerivedNauseaEpirubicinWeight GainDrug Therapy, CombinationQuestionnairesRemission InductionInterferon-alphaDisease ProgressionLeukopeniaPatient ComplianceDrug EvaluationRenal DialysisDietary SupplementsInjections, IntravenousChemoradiotherapyOrganoplatinum CompoundsPeritoneal Dialysis, Continuous AmbulatoryFatigueDimethylhydrazinesEtidronic AcidCarcinoma, Non-Small-Cell LungCyclophosphamideDiarrheaCarcinoma, Squamous Cell1,2-DimethylhydrazinePlacebosHead and Neck NeoplasmsRecurrenceUreaKidney Failure, ChronicDietVinblastineDose FractionationAlcohol DrinkingDisease Models, AnimalSalvage TherapyPregnancyBone Density Conservation AgentsPyrazinesCarcinogensColonic NeoplasmsThrombocytopeniaAnalysis of VarianceSeverity of Illness IndexIndonesiaRisk FactorsPapillomaNeoplasm Recurrence, Local